3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
2
Status
Recruiting
4
Terminated
2
Active not recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
CNS
2
Conditions
Xanthomatosis, Cerebrotendinous
1
Influenza, Human
1
Glioma
1
Diffuse Intrinsic Pontine Glioma
1
Brain Neoplasms
1
Interventions
pembrolizumab
116
Carboplatin
46
Nivolumab
45
Paclitaxel
34
Cyclophosphamide
34
Cisplatin
32
Gemcitabine
30
atezolizumab
28
Specimen Handling
26
venetoclax
25
Magnetic Resonance Spectroscopy
24
Docetaxel
24
fludarabine
23
Pemetrexed
23
Biopsy
22
Bevacizumab
22
Radiotherapy
21
Ipilimumab
21
Azacitidine
21
Dexamethasone
19
durvalumab
18
Radiosurgery
18
Fluorouracil
17
Cetuximab
16
Trastuzumab
15
fludarabine phosphate
14
Leucovorin
14
Cytarabine
14
tislelizumab
13
Lenalidomide
13
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Terminated
×
Diphtheria-Tetanus Vaccine
×
1 year
×
Clear all
NCT03334305
2026-04-23
ACTION
University of Florida
Phase 1
Terminated
18 enrolled
11 charts
NCT03396575
2025-10-29
BRAVO
University of Florida
Phase 1
Terminated
11 enrolled